Abstract:Background & aims: Previous research established that the availability of L-arginine affects placental vascular development and fetal growth. However, practical details associated with the effects of L-arginine supplementation on the neonatal outcomes of hypertensive disorder (HD) and intrauterine growth restriction (IUGR) pregnancies are limited. Methods: The PubMed, ScienceDirect, and Web of Science databases were searched for peer-reviewed literature published by September 30, 2021 to investigate the operational details of L-arginine supplementation in improving neonatal outcomes in complicated pregnancies. Standardized mean difference (SMD) and weighted mean difference (WMD) of continuous variables, as well as the risk ratio (RR) for categorical variables were pooled by random-effects models. Results: The results indicated that L-arginine supplementation increased the plasma nitric oxide (NO) concentrations in IUGR pregnancies (SMD: 0.71; 95% CI: 0.45, 0.97; I-2 = 0%), but decreased the risk of preeclampsia in HD mothers (RR: 0.49; 95% CI: 0.31, 0.76; I-2 = 0%). Administration with L-arginine elevated birth weights both in hypertensive and IUGR pregnant women, with WMDs of 194.70 g (95% CI: 58.21, 331.20; I-2 = 44.2%) and 134.00 g (95% CI: 43.53, 224.46; I-2 = 42.4%), respectively. However, the intervention had no effect on gestational age except in HD pregnancies (WMD: 7.05 d; 95% CI: 3.16, 10.95; I-2 = 36.5%). L-arginine administration during pregnancy significantly reduced the small for gestational age (SGA) risk of fetus both in HD (RR: 0.51; 95% CI: 0.31, 0.83; I-2 = 0.0%) and IUGR mothers (RR: 0.46; 95% CI: 0.25, 0.88; I-2 = 0.0%). Subgroup analyses revealed that L-arginine supplementation at <4 g/ d dosage or for >1-month duration or in the third trimester had a greater effect on birth weights in HD women without proteinuria, but a higher L-arginine dosage was more beneficial for extending gestational age and reducing the risk of SGA in older pregnancies. Additionally, intravenous infusion of L-arginine, but not oral administration, significantly increased birth weight in IUGR pregnancies with elevated NO concentrations, although the recommended amount should be confined to <4 g/d. Conclusions: These findings provide practical guidelines for L-arginine supplementation to improve the birth outcomes of complicated pregnancies. Registry number: CRD42021246290 (https://www.crd.york.ac.uk/PROSPERO). (C) 2022 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Antenatal low‐intensity pulsed ultrasound reduces neurobehavioral deficits and brain injury following dexamethasone‐induced intrauterine growth restriction

Postnatal Delayed Growth Impacts Cognition but Rescues Programmed Impaired Pulmonary Vascular Development in an IUGR Rat Model

Early moderate catch-up growth after birth helps IUGR rats achieve good pulmonary vascular and cognitive function in adulthood

L-arginine supplementation improved neonatal outcomes in pregnancies with hypertensive disorder or intrauterine growth restriction: A systematic review and meta-analysis of randomized controlled trials

Antenatal dexamethasone retarded fetal long bones growth and development by down-regulating of insulin-like growth factor 1 signaling in fetal rats

Nutritional Intervention for Developmental Brain Damage: Effects of Lactoferrin Supplementation in Hypocaloric Induced Intrauterine Growth Restriction Rat Pups

Uteroplacental insufficiency affects epigenetic determinants of chromatin structure in brains of neonatal and juvenile IUGR rats.

Prenatal Dexamethasone Exposure Exerts Sex-Specific Effect on Placental Oxygen and Nutrient Transport Ascribed to the Differential Expression of IGF2.

Prenatal Dexamethasone Exposure Induced Alterations in Neurobehavior and Hippocampal Glutamatergic System Balance in Female Rat Offspring

Dimethylglycine Sodium Salt Alleviates Intrauterine Growth Restriction-Induced Low Growth Performance, Redox Status Imbalance, and Hepatic Mitochondrial Dysfunction in Suckling Piglets

Effect of Postnatal Nutrition Restriction on the Oxidative Status of Neonates with Intrauterine Growth Restriction in a Pig Model.

Progressive disruption of neurodevelopment by mid-gestation exposure to lipopolysaccharides and the ameliorating effect of continuous alpha-glycosyl isoquercitrin treatment

Inosine pretreatment of pregnant rats ameliorates maternal inflammation-mediated hypomyelination in pups via microglia polarization switch

Neonatal and Juvenile IUGR Rats Determinants of Chromatin Structure in Brains of Uteroplacental Insufficiency Affects Epigenetic

A Model of Intrauterine Growth Restriction Was Induced by Bilateral Uterine Vessel Clamping in Pregnant Rats

A Synthetic Analog of Lipoxin A4 Partially Alleviates Dexamethasone-Induced Fetal Growth Restriction in Rats.

Treatment of Immune Dysfunction in Intrauterine Growth Restriction Piglets Via Supplementation with Dimethylglycine Sodium Salt During the Suckling Period.

Polyphenols and IUGR Pregnancies: Intrauterine Growth Restriction and Hydroxytyrosol Affect the Development and Neurotransmitter Profile of the Hippocampus in a Pig Model

Maternal Curcumin Supplementation Ameliorates Placental Function and Fetal Growth in Mice with Intrauterine Growth Retardation†

Intrauterine Growth Restriction Alters Postnatal Hippocampal Dentate Gyrus Neuron and Microglia Morphology and Cytokine/Chemokine Milieu in Mice

Maternal L-glutamine Supplementation During Late Gestation Alleviates Intrauterine Growth Restriction-Induced Intestinal Dysfunction in Piglets.